World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
66
Citations
22327
World Ranking
2721
National Ranking
114

Guy Gorochov publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Guy Gorochov sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 240 publications — 48th percentile

48% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Guy Gorochov D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Guy Gorochov sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 66 D-Index — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Guy Gorochov is affiliated with Sorbonne University in France. Their research primarily focuses on the field of Medicine, with significant specialization in Infectious Diseases, Immunology, Neurology, Rheumatology, and Genetics. The main topics of their work revolve around SARS-CoV-2 and COVID-19 research, COVID-19 clinical research studies, long-term effects of COVID-19, systemic lupus erythematosus research, immune cell function and interaction, T-cell and B-cell immunology, and immunodeficiency and autoimmune disorders.

Gorochov has contributed to a substantial body of research, including several recent papers such as:

  • "Autoantibodies against type I IFNs in patients with life-threatening COVID-19" (2020, Science)
  • "IgA dominates the early neutralizing antibody response to SARS-CoV-2" (2020, Science Translational Medicine)
  • "Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers" (2021, Nature Communications)
  • "IgA dominates the early neutralizing antibody response to SARS-CoV-2" (2020, bioRxiv [Cold Spring Harbor Laboratory])
  • "Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott-Aldrich syndrome" (2022, Nature Medicine)

Their frequent co-authors include Karim Dorgham, Makoto Miyara, Delphine Sterlin, Christophe Parizot, and Zahir Amoura. These collaborations appear consistently across Gorochov's publications, indicating a collaborative research approach.

Publications featuring Gorochov frequently appear in notable venues, including:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • La Revue de Médecine Interne
  • Frontiers in Immunology
  • The Journal of Experimental Medicine
  • Annals of the Rheumatic Diseases

Best Publications

  • Autoantibodies against type I IFNs in patients with life-threatening COVID-19.

    Paul Bastard;Paul Bastard;Paul Bastard;Lindsey B. Rosen;Qian Zhang;Eleftherios Michailidis

  • Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription Factor

    Makoto Miyara;Yumiko Yoshioka;Akihiko Kitoh;Tomoko Shima

  • Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

    Qian Zhang;Paul Bastard;Paul Bastard;Zhiyong Liu;Jérémie Le Pen

  • IgA dominates the early neutralizing antibody response to SARS-CoV-2.

    Delphine Sterlin;Delphine Sterlin;Alexis Mathian;Makoto Miyara;Audrey Mohr

  • Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells.

    Manuelle Viguier;Fabrice Lemaître;Olivier Verola;Min Sun Cho

  • Autoantibodies neutralizing type I IFNs are present in ~ 4% of uninfected individuals over 70 years old and account for ~ 20% of COVID-19 deaths.

    Paul Bastard;Adrian Gervais;Adrian Gervais;Tom Le Voyer;Tom Le Voyer;Jérémie Rosain;Jérémie Rosain

  • Global Natural Regulatory T Cell Depletion in Active Systemic Lupus Erythematosus

    Makoto Miyara;Zahir Amoura;Christophe Parizot;Cécile Badoual

  • Perturbation of CD4 + and CD8 + T-cell repertoires during progression to AIDS and regulation of the CD4 + repertoire during antiviral therapy

    Guy Gorochov;Avidan U. Neumann;Avidan U. Neumann;Anne Kereveur;Christophe Parizot

  • The immune paradox of sarcoidosis and regulatory T cells

    Makoto Miyara;Zahir Amoura;Christophe Parizot;Cécile Badoual

  • Human FoxP3+ regulatory T cells in systemic autoimmune diseases

    Makoto Miyara;Guy Gorochov;Michael Ehrenstein;Lucile Musset

  • Transcriptional Blood Signatures Distinguish Pulmonary Tuberculosis, Pulmonary Sarcoidosis, Pneumonias and Lung Cancers

    Chloe I. Bloom;Christine M. Graham;Matthew P. R. Berry;Matthew P. R. Berry;Fotini Rozakeas

  • Pathogenesis of Takayasu's arteritis: a 2011 update.

    Laurent Arnaud;Julien Haroche;Julien Haroche;Alexis Mathian;Alexis Mathian;Guy Gorochov;Guy Gorochov

  • Microbial ecology perturbation in human IgA deficiency

    Jehane Fadlallah;Hela El Kafsi;Delphine Sterlin;Catherine Juste

  • The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies

    Unknown

  • In-cell PCR from mRNA: amplifying and linking the rearranged immunoglobulin heavy and light chain V-genes within single cells

    M.J. Embleton;Guy Gorochov;Peter T. Jones;Greg Winter

  • Intracerebral administration of CpG oligonucleotide for patients with recurrent glioblastoma: a phase II study

    Alexandre Carpentier;Philippe Metellus;Renata Ursu;Sarah Zohar

  • Effect of tyrosine kinase inhibitor STI571 on the kinase activity of wild-type and various mutated c-kit receptors found in mast cell neoplasms.

    Yael Zermati;Paulo De Sepulveda;Frederic Féger;Sebastion Létard

  • Systemic perturbation of cytokine and chemokine networks in Erdheim-Chester disease: a single-center series of 37 patients.

    Laurent Arnaud;Guy Gorochov;Guy Gorochov;Frédéric Charlotte;Virginie Lvovschi

  • Generation of effector T cells expressing chimeric T cell receptor with antibody type-specificity.

    G Gross;G Gorochov;T Waks;Z Eshhar

  • HIV disease progression despite suppression of viral replication is associated with exhaustion of lymphopoiesis

    Delphine Sauce;Martin Larsen;Solène Fastenackels;Michèle Pauchard

  • Restoration of the immune system with anti-retroviral therapy.

    Brigitte Autran;Guislaine Carcelaint;Taisheng S. Li;Guy Gorochov

  • Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers.

    Stéphane Marot;Isabelle Malet;Valentin Leducq;Karen Zafilaza

Frequent Co-Authors

Zahir Amoura
Zahir Amoura Université Paris Cité
Hans Yssel
Hans Yssel Sorbonne University
Patrice Debré
Patrice Debré Sorbonne University
Lucile Musset
Lucile Musset Sorbonne University
Brigitte Autran
Brigitte Autran Sorbonne University
Flore Rozenberg
Flore Rozenberg Université Paris Cité
Claire Fieschi
Claire Fieschi Université Paris Cité
Anne Caignard
Anne Caignard Grenoble Alpes University
Alain Schmitt
Alain Schmitt Institut Cochin
Eric Oksenhendler
Eric Oksenhendler Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Immunology opens doors to a variety of specialized healthcare careers. Many students consider advancing into nursing roles that complement their scientific background. For example, those already in nursing might explore an fnp to acute care np bridge program to expand their clinical expertise into acute care settings, bridging primary care and critical patient management.

For individuals looking to accelerate their nursing career, enrolling in an accelerated fnp program offers a fast-track way to become a Family Nurse Practitioner, gaining valuable experience in patient care along the way.

Those without a nursing background but interested in transitioning into nursing can find opportunities through online rn programs for non nurses in Florida. Such programs cater specifically to non-nurses, providing comprehensive education to enter the nursing field.

Additionally, students seeking an accessible path to nursing may consider options like the easiest absn to get into. These programs offer a streamlined admission process while ensuring quality education for aspiring nurses, often accommodating those balancing work and study.

Best Scientists Citing Guy Gorochov

Trending Scientists

Recently Published Articles